Resource

Biohazardous Waste Segregation Rules in California

Container colors, what counts as biohazardous, sharps vs pathological vs trace chemo, and the documentation regulators expect.

Biohazardous waste segregation is one of the most-cited compliance gaps in California healthcare facilities. The rules are not complicated, but the consequences of getting them wrong are expensive: inflated disposal costs (30-50% common), incorrect manifesting, and citations from CDPH, Cal/OSHA, or DTSC depending on the stream.

This guide covers the seven segregation buckets, treatment differences that drive cost, and the most common mistakes that show up in CUPA and CDPH inspections.

Seven Segregation Buckets

Biohazardous waste (red)

Contents: Blood-soaked items, IV tubing with blood, gowns with body fluids, lab cultures, gloves with visible contamination.

Treatment: STAATT-IV alternative treatment (preferred via NETZERO|360 EnvoMed 80) or autoclave at registered facility.

Sharps waste (red, puncture-resistant)

Contents: Needles, syringes with attached needles, scalpels, lancets, broken glass with biological material.

Treatment: Same as biohazardous, but in puncture-resistant containers per Cal/OSHA 5193.

Pathological waste (red, separate manifest)

Contents: Human tissues, organs, body parts removed during surgery or autopsy.

Treatment: Incineration only per H&SC 118222. Cannot be autoclaved in California.

Trace chemotherapy waste (yellow)

Contents: Empty IV bags, tubing, gloves, gowns that contacted antineoplastic agents but contain no bulk drug.

Treatment: Incineration. Separate manifest line from biohazardous.

Bulk chemotherapy waste (black or RCRA-coded)

Contents: Spilled chemo, unused chemo, drug-containing residues meeting RCRA hazardous characteristics.

Treatment: RCRA hazardous waste protocols, not medical waste protocols. Different manifesting.

Pharmaceutical waste (blue or labeled)

Contents: Expired or unused non-controlled medications, IV preparations, vaccine residues.

Treatment: Pharmaceutical waste pathway. DEA-controlled substances require separate reverse-distribution chain of custody.

Non-regulated waste (clear or standard)

Contents: Non-contaminated packaging, paper, gloves with no visible contamination, food-service items.

Treatment: Standard solid waste. Source-separation under SB 1383 and AB 341 may apply.

Five Common Segregation Mistakes

Mistake: Pathological waste in biohazardous red bag

Fix: Pathological waste requires incineration and a separate manifest. Cal MWMA H&SC 118222 prohibits autoclaving. Use separate containers.

Mistake: Trace chemo in biohazardous bin

Fix: Trace chemo (yellow) is incinerated, biohazardous is autoclaved or STAATT-treated. Different disposal cost, different documentation.

Mistake: Bulk chemo treated as medical waste

Fix: Bulk chemo is RCRA hazardous, not medical waste. Wrong stream = federal RCRA violation, much higher penalties.

Mistake: Non-contaminated trash in red bag

Fix: Inflates billable medical waste weight by 30-50% in most facilities. Costs you money and creates incorrect downstream documentation.

Mistake: Sharps in regular biohazardous bag

Fix: Sharps require puncture-resistant containers per Cal/OSHA 5193. Bag-only containment is a violation that gets cited.

Segregation gets each stream into the right container, and our biohazard waste disposal service handles the scheduled pickup, manifesting, and treatment from there.

Waste audit + training cuts billable weight 20-40%

Most facilities can reduce medical waste costs significantly just by fixing segregation. Audit included in COMPLIANCE|360.

See medical waste service

FAQ

Per H&SC 117635, biohazardous waste includes any waste containing or contaminated with blood, body fluids, or other potentially infectious materials. Common examples: blood-soaked items, IV tubing with visible blood, lab cultures, gloves with visible body-fluid contamination.

Biohazardous waste is contaminated items (gauze, tubing, gloves). Pathological waste is human tissue, organs, or body parts. Different treatment requirements: biohazardous can be autoclaved or STAATT-treated; pathological MUST be incinerated per H&SC 118222.

Trace chemo requires incineration. Regular biohazardous typically uses lower-cost alternative treatment (autoclave, STAATT-IV). Mixing them forces the entire bin into incineration treatment, inflating costs 3-5x for the biohazardous portion.

Red for biohazardous and sharps. Yellow for trace chemotherapy. Black or RCRA-coded for bulk chemotherapy and hazardous pharmaceutical waste. Blue or labeled for non-controlled pharmaceutical waste. Color coding is a Cal/OSHA and CDPH expectation; not perfectly standardized federally but consistent in practice.

Three things work: visible color-coded container placement at the point of use (not just in central storage), annual training that includes specific examples of what does and doesn't go in red, and waste audits that quantify the cost impact and feed back to clinical teams.

Primary enforcement is CDPH and local health departments. Cal/OSHA enforces sharps-container and bloodborne pathogen aspects. DTSC enforces hazardous-classified streams (bulk chemo, certain pharma waste). Multiple agencies can cite for the same segregation failure.

Yes. We provide waste-stream audits that quantify segregation gaps, staff training tailored to your facility's specific waste mix, and color-coded container setup. Most clients reduce billable medical waste weight by 20-40% through segregation training alone.

Ready to Simplify Your Compliance?

One vendor for waste disposal, training, and regulatory compliance across the Bay Area, led by the 2025 NRC Recycler of the Year. Get a free assessment today.

833-247-OSHAGet My Quote